Glaxo, Inc. v. Novopharm, Ltd.

Core Citations

STATUTE OVERRULES

• Roche Products, Inc. v. Bolar Pharmaceutical Co., Inc.

CITED in

• Endo Pharms. Inc. v. Teva Pharms. United States, Inc., 2015-2021

This document cites

• Federal Cases - Baldwin Hardware Corp. v. Franksu Enterprise Corp.
• Federal Cases - Aetna Life Ins Co of Hartford, Conn v. Haworth
• Federal Cases - Molins PLC v. Quigg
• Federal Cases - Fromson v. Advance Offset Plate, Inc.
• Federal Cases - Eli Lilly and Company v. Medtronic, Inc



See all quotations

• Federal Cases - Roche Products, Inc. v. Bolar Pharmaceutical Co., Inc.
• Federal Cases - Telectronics Pacing Systems, Inc. v. Ventritex, Inc.
• Federal Cases - Astra v. Lehman
• Federal Cases - Loveladies Harbor, Inc. v. U.S.
• Federal Cases - Glaxo Inc. v. Novopharm Ltd., 94-1026
• Federal Cases - Bristol-Myers Squibb Co. v. Royce Laboratories, Inc.
• Federal Cases - Louisville Nashville Railroad Company v. Erasmus Mottley
• Federal Cases - Zenith Laboratories, Inc. v. Bristol-Myers Squibb Co., BRISTOL-MYERS
• Federal Cases - Dolly, Inc. v. Spalding & Evenflo Companies, Inc., 93-1233
• Federal Cases - Markman v. Westview Instruments
• Federal Cases - Glasser v. A.H. Robins Co., Inc., 89-1061
• Federal Cases - Lang v. Pacific Marine and Supply Co., Ltd.
• Federal Cases - Carroll Touch, Inc. v. Electro Mechanical Systems, Inc.
• Federal Cases - Spectronics Corp. v. H.B. Fuller Co., Inc.
• Federal Cases - Skelly Oil Co v. Phillips Petroleum Co
• Federal Cases - Minnesota Min. and Mfg. Co. v. Norton Co.
• Federal Cases - Markman v. Westview Instruments, Inc.
• Federal Cases - Glaxo, Inc. v. Novopharm Ltd., 91-759-CIV-5-BO.
• US - Reference Stubs - Content and format of an abbreviated application
• US - Reference Stubs - Jurisdiction of the United States Court of Appeals for the Federal Circuit
• US - Reference Stubs - Creation of remedy
• US - Reference Stubs - Infringement of patent
• US - Reference Stubs - New drugs
• US - Reference Stubs - Claim for Relief Arising under 35 U.S.C. Section 271(e)(2) or 42 U.S.C. Section 262